Sanjiv Patel has sold RLAY and made no open-market buys since Apr 2022

Sanjiv K. Patel, M.D. is the President, Chief Executive Officer, and Class I Director of Relay Therapeutics, Inc. (RLAY), a precision oncology company, a role he has held since March 2017.( Age 51, Dr. Patel leads the company's innovative '3D movie platform' for drug discovery, focusing on oncology and previously undruggable targets.(

Dr. Patel brings extensive experience from a decade at Allergan, Inc., where he served as Executive Vice President and Chief Strategy Officer (2015–2017), Corporate Vice President of Global Strategic Marketing & Global Health Outcomes (2013–2015), and various strategy and marketing roles (2006–2013).( Earlier, he worked as a management consultant at The Boston Consulting Group and as a surgeon in the UK National Health Service.( His education includes a Doctorate from the University of London, an MBA from INSEAD, and a graduate degree from the University of Cambridge; he is a Member of The Royal College of Surgeons of England.( Dr. Patel has served on boards including Prothena Corporation (2021–2023) and ARYA Sciences Acquisition Corp V (2021–2023).(

Written by Perplexity from public sources.